595 related articles for article (PubMed ID: 36945046)
1. Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications.
Zhao B; Wu B; Feng N; Zhang X; Zhang X; Wei Y; Zhang W
J Hematol Oncol; 2023 Mar; 16(1):28. PubMed ID: 36945046
[TBL] [Abstract][Full Text] [Related]
2. Senescence and the tumor-immune landscape: Implications for cancer immunotherapy.
Chibaya L; Snyder J; Ruscetti M
Semin Cancer Biol; 2022 Nov; 86(Pt 3):827-845. PubMed ID: 35143990
[TBL] [Abstract][Full Text] [Related]
3. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
D'Ambrosio M; Gil J
Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment.
Deng Y; Chen Q; Yang X; Sun Y; Zhang B; Wei W; Deng S; Meng J; Hu Y; Wang Y; Zhang Z; Wen L; Huang F; Wan C; Yang K
Theranostics; 2024; 14(3):1224-1240. PubMed ID: 38323313
[No Abstract] [Full Text] [Related]
5. Senescence and Immunotherapy: Redundant Immunomodulatory Pathways Promote Resistance.
Oesterreich S; Aird KM
Cancer Immunol Res; 2023 Apr; 11(4):401-404. PubMed ID: 36826438
[TBL] [Abstract][Full Text] [Related]
6. Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging.
Han X; Lei Q; Xie J; Liu H; Li J; Zhang X; Zhang T; Gou X
J Gerontol A Biol Sci Med Sci; 2022 Nov; 77(11):2207-2218. PubMed ID: 35524726
[TBL] [Abstract][Full Text] [Related]
7. Macrophages and tumor-associated macrophages in the senescent microenvironment: From immunosuppressive TME to targeted tumor therapy.
Du M; Sun L; Guo J; Lv H
Pharmacol Res; 2024 Jun; 204():107198. PubMed ID: 38692466
[TBL] [Abstract][Full Text] [Related]
8. Cellular senescence and the tumour microenvironment.
Takasugi M; Yoshida Y; Ohtani N
Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
[TBL] [Abstract][Full Text] [Related]
9. The impact of the senescent microenvironment on tumorigenesis: Insights for cancer therapy.
Zhang W; Zhang K; Shi J; Qiu H; Kan C; Ma Y; Hou N; Han F; Sun X
Aging Cell; 2024 May; 23(5):e14182. PubMed ID: 38650467
[TBL] [Abstract][Full Text] [Related]
10. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
Chambers CR; Ritchie S; Pereira BA; Timpson P
Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
[TBL] [Abstract][Full Text] [Related]
11. KDM4 Orchestrates Epigenomic Remodeling of Senescent Cells and Potentiates the Senescence-Associated Secretory Phenotype.
Zhang B; Long Q; Wu S; Xu Q; Song S; Han L; Qian M; Ren X; Liu H; Jiang J; Guo J; Zhang X; Chang X; Fu Q; Lam EW; Campisi J; Kirkland JL; Sun Y
Nat Aging; 2021 May; 1(5):454-472. PubMed ID: 34263179
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence.
Salminen A; Kauppinen A; Kaarniranta K
Biogerontology; 2018 Oct; 19(5):325-339. PubMed ID: 29959657
[TBL] [Abstract][Full Text] [Related]
13. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
Luo Y; Liu H; Fu H; Ding GS; Teng F
Front Immunol; 2022; 13():974377. PubMed ID: 36458010
[TBL] [Abstract][Full Text] [Related]
14. The role of cellular senescence and SASP in tumour microenvironment.
Takasugi M; Yoshida Y; Hara E; Ohtani N
FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
[TBL] [Abstract][Full Text] [Related]
15. TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state.
Matsuda S; Revandkar A; Dubash TD; Ravi A; Wittner BS; Lin M; Morris R; Burr R; Guo H; Seeger K; Szabolcs A; Che D; Nieman L; Getz GA; Ting DT; Lawrence MS; Gainor J; Haber DA; Maheswaran S
Cell Rep; 2023 Mar; 42(3):112129. PubMed ID: 36821441
[TBL] [Abstract][Full Text] [Related]
16. Effects of senescence on the tumour microenvironment and response to therapy.
Reynolds LE; Maallin S; Haston S; Martinez-Barbera JP; Hodivala-Dilke KM; Pedrosa AR
FEBS J; 2024 Jun; 291(11):2306-2319. PubMed ID: 37873605
[TBL] [Abstract][Full Text] [Related]
17. Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy.
Liu X; Si F; Bagley D; Ma F; Zhang Y; Tao Y; Shaw E; Peng G
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36192086
[TBL] [Abstract][Full Text] [Related]
18. "Bone-SASP" in Skeletal Aging.
Fang CL; Liu B; Wan M
Calcif Tissue Int; 2023 Jul; 113(1):68-82. PubMed ID: 37256358
[TBL] [Abstract][Full Text] [Related]
19. Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond.
Zhao Y; Du J; Shen X
Front Immunol; 2023; 14():1157537. PubMed ID: 37006306
[TBL] [Abstract][Full Text] [Related]
20. [The role of SASP in tumor microenvironment.].
Ohtani N
Clin Calcium; 2017; 27(6):835-843. PubMed ID: 28536322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
